The NC incorporates a protein nanoparticle to selectively internalize in CXCR4+ AML cells by exploiting high CXCR4 overexpression in LSCs as compared to HSCs [6, 20], similarly to a previous approach in colorectal cancer (CRC) [21, 22]. Here, CXCR4 is linked to colorectal cancer.